Increased uric acid levels in bipolar disorder subjects during different phases of illness

Journal of Affective Disorders

Volumn 173, Issue , 2015, Pages 170-175

  Albert, Umberto ^a   De Cori, David ^a   Aguglia, Andrea ^a   Barbaro, Francesca ^a   Bogetto, Filippo ^a   Maina, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bipolar disorder; Mania; Uric acid

Indexed keywords

MOOD STABILIZER; URIC ACID; VALPROIC ACID; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DSM-IV; FEMALE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; PATHOPHYSIOLOGY; POST HOC ANALYSIS; SCHIZOPHRENIA; URIC ACID BLOOD LEVEL; YOUNG MANIA RATING SCALE; BLOOD; CYCLOTHYMIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MIDDLE AGED; PSYCHOLOGY;

ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CYCLOTHYMIC DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; URIC ACID;

EID: 84912056807     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.11.005     Document Type: Article

References (31)

1. Akhondzadeh, S., Milajerdi, M.R., Amini, H., et al., 2006. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a doubleblind, randomized, placebo-controlled trial. Bipolar Disord. 8, 485-489.
2. Anumonye, A., Reading, H.W., Knight, F., et al., 1968. Uric-acid metabolism in manic-depressive illness and during lithium therapy. Lancet 1 (7555), 1290-1293.
3. Boison, D., 2008. Adenosine as a neuromodulator in neurological diseases. Curr. Opin. Pharmacol. 8 (1), 2-7.
4. Bowman, G.L., Shannon, J., Frei, B., et al., 2010. Uric acid as a CNS antioxidant. J. Alzheimers Dis. 19, 1331-1336.
5. Burnstock, G., 2008. Purinergic signaling and disorders of the central nervous system. Nat. Rev. Drug Discov. 7, 575-590.
6. Chung, K.H., Huang, C.C., Lin, H.C., 2010. Increased risk of gout among patients with bipolar disorder: a nationwide population-based study. Psychiatry Res. 180 (2-3), 147-150.
7. De Berardis, D., Conti, C.M., Campanella, D., et al., 2008. Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder. J. Biol. Regul. Homeost. Agents 22 (3), 195-200.
8. Fan, A., Berg, A., Bresee, C., et al., 2012. Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study. Bipolar Disord. 14, 206-210.
9. Geddes, J.R., Miklowitz, D.J., 2013. Treatment of bipolar disorder. Lancet 381, 1672-1682.
10. Hamilton, M., 1960. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56-62.
11. Hirota, T., Kishi, T., 2013. Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators. Schizophr. Res. 149, 88-95.
12. Jahangard, L., Soroush, S., Haghighi, M., et al., 2014. In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder. Eur. Neuropsychopharmacol. 24 (8), 1210-1221.
13. Kesebir, S., Süner, O., Yaylaci, E.T., Bayrak, A., Turan, C., 2013. Increased uric acid levels in bipolar disorder: is it trait or state? J. Biol. Regul. Homeost. Agents. 27 (4), 981-988.
14. Kesebir, S., Yaylaci, E.T., Suner, O., et al., 2014. Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: the role of affective temperament. J Affect. Disord. 165, 131-134.
15. Kraepelin, E., 1921. Manic-Depressive Insanity and Paranoia.
16. Lara, D.R., Dall'Igna, O.P., Ghisolfi, E.S., et al., 2006. Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 617-629.
17. Lorenzi, T.M., Borba, D.L., Dutra, G., et al., 2010. Association of serum uric acid levels with emotional and affective temperaments. J. Affect. Disord. 121 (1-2), 161-164.
18. Machado-Vieira, R., Soares, J.C., Lara, D.R., et al., 2008. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in bipolar mania. J. Clin. Psychiatry 69 (8), 1237-1245.
19. Machado-Vieira, R., 2012. Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania. J. Clin. Psychopharmacol. 32 (5), 735-736.
20. Machado-Vieira, R., Lara, D.R., Souza, D.O., Kapczinski, F., 2002. Purinergic dysfunction in mania: an integrative model. Med. Hypotheses 58 (4), 297-304.
21. Merikangas, K.R., Akiskal, H.S., Angst, J., et al., 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch. Gen. Psychiatry 64, 543-552.
22. Merikangas, K.R., Jin, R., He, J.P., et al., 2011. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch. Gen. Psychiatry 68, 241-251.
23. Oruch, R., Elderbi, M.A., Khattab, H.A., et al., 2014. Lithium: a review of pharmacology, clinical uses, and toxicity. Eur. J. Pharmacol. 740, 464-473.
24. Ring, H.A., Heller, A.J., Marshall, W.J., et al., 1991. Plasma uric acid levels in patients receiving anticonvulsant monotherapy. Epilepsy Res. 8 (3), 241-244.
25. Salvadore, G., Viale, C.I., Luckenbaugh, D.A., et al., 2010. Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode. Prog. Neuropsychopharmacol. Biol. Psychiatry 34 (6), 819-821.
26. Salvi, V., Albert, U., Chiarle, A., et al., 2008. Metabolic syndrome in Italian patients with bipolar disorder. Gen. Hosp. Psychiatry 30, 318-323.
27. Sutin, A.R., Cutler, R.G., Camandola, S., et al., 2014. Impulsivity in associated with uric acid: evidence from Humans and Mice. Biol. Psychiatry 75, 31-37.
28. Weiser, M., Burshtein, S., Gershon, A.A., et al., 2014. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder. Bipolar Disord. 16, 441-447.
29. Wen, S., Cheng, M., Wang, H., et al., 2012. Serum uric acid levels and the clinical characteristics of depression. Clin. Biochem. 45, 49-53.
30. Wiener, C., Rassier, G.T., Kaster, M.P., et al., 2014. Gender-based differences in oxidative stress parameters do not underlie the the differences in mood disorders susceptibility between sexes. Eur. Psychiatry 29, 58-63.
31. Young, R.C., Biggs, J.T., Ziegler, V.E., et al., 1978. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133, 429-435.